A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome
- PMID: 22870010
- PMCID: PMC3409915
- DOI: 10.4103/0974-1208.97789
A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome
Abstract
Objectives: To compare the efficacy of letrozole and clomiphene citrate (CC) in patients of anovulatory polycystic ovarian syndrome (PCOS) with infertility.
Materials and methods: This prospective randomized clinical trial included 204 patients of PCOS. 98 patients (294 cycles) received 2.5-5 mg of letrozole; 106 patients (318 cycles) received 50-100 mg of CC (both orally from Days 3-7 of menstrual cycle). The treatment continued for three cycles in both the groups.
Main outcome measures: ovulation rate, endometrial thickness, and pregnancy rate. Statistical analysis was done using SPSS 13 software. P value less than 0.05 was considered significant.
Results: The mean number of dominant follicles in letrozole groups and CC groups was 1.86±0.26 and 1.92±0.17, respectively (P=0.126). Number of ovulatory cycle in letrozole group was 196 (66.6%) versus 216 (67.9%) in CC group (P=0.712). The mean mid-cycle endometrial thickness was 9.1±0.3 mm in letrozole group and 6.3±1.1 in CC group, which was statistically significant (P=0.014). The mean Estradiol [E2] level in clomiphene citrate group was significantly higher in CC group (364.2±71.4 pg/mL) than letrozole group (248.2± 42.2 pg/mL). 43 patients from the letrozole group (43.8%) and 28 patients from the CC group (26.4%) became pregnant.
Conclusion: Letrozole and CC have comparable ovulation rate. The effect of letrozole showed a better endometrial response and pregnancy rate compared with CC.
Keywords: Clomiphene citrate; PCOS; letrozole; randomized trial.
Conflict of interest statement
Figures
Similar articles
-
Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.Hum Reprod. 2017 Aug 1;32(8):1631-1638. doi: 10.1093/humrep/dex227. Hum Reprod. 2017. PMID: 28854590 Free PMC article. Clinical Trial.
-
Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: A randomized controlled trial.Int J Gynaecol Obstet. 2021 Mar;152(3):345-350. doi: 10.1002/ijgo.13375. Epub 2020 Oct 14. Int J Gynaecol Obstet. 2021. PMID: 32920843 Clinical Trial.
-
Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.Fertil Steril. 2009 Sep;92(3):853-857. doi: 10.1016/j.fertnstert.2007.08.044. Epub 2008 Jan 4. Fertil Steril. 2009. PMID: 18177867 Clinical Trial.
-
Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials.Arch Gynecol Obstet. 2018 May;297(5):1081-1088. doi: 10.1007/s00404-018-4688-6. Epub 2018 Feb 1. Arch Gynecol Obstet. 2018. PMID: 29392438
-
Letrozole Compared With Clomiphene Citrate for Unexplained Infertility: A Systematic Review and Meta-analysis.Obstet Gynecol. 2019 Mar;133(3):437-444. doi: 10.1097/AOG.0000000000003105. Obstet Gynecol. 2019. PMID: 30741800
Cited by
-
Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial.Front Endocrinol (Lausanne). 2024 Jan 15;14:1294339. doi: 10.3389/fendo.2023.1294339. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38283747 Free PMC article. Clinical Trial.
-
Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway.Exp Ther Med. 2018 Feb;15(2):2120-2127. doi: 10.3892/etm.2017.5650. Epub 2017 Dec 15. Exp Ther Med. 2018. PMID: 29434814 Free PMC article.
-
Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction.Hum Reprod. 2022 Apr 1;37(4):793-805. doi: 10.1093/humrep/deac005. Hum Reprod. 2022. PMID: 35048945 Free PMC article.
-
Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility.Cureus. 2023 Aug 31;15(8):e44493. doi: 10.7759/cureus.44493. eCollection 2023 Aug. Cureus. 2023. PMID: 37791160 Free PMC article. Review.
-
The management of patients with polycystic ovary syndrome.Nat Rev Endocrinol. 2014 Oct;10(10):624-36. doi: 10.1038/nrendo.2014.102. Epub 2014 Jul 15. Nat Rev Endocrinol. 2014. PMID: 25022814 Review.
References
-
- Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab. 2002;87:569–74. - PubMed
-
- Fisher SA, Reid RL, Van Vugt DA, Casper RF. A Randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril. 2002;78:280–5. - PubMed
-
- Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82:1561–3. - PubMed
-
- Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56:465–8. - PubMed
-
- Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril. 1997;67:256–60. - PubMed
LinkOut - more resources
Full Text Sources